Tonix's lead drug fails PhI­II again, send­ing stock even clos­er to ze­ro

4 years ago
R&D

No­vo-part­nered mi­cro­cap biotech forced to halt PhI­II en­roll­ment in Rus­sia and Ukraine as war con­tin­ues

4 years ago
Pharma

Tiny Val­lon’s at­tempt at break­ing in­to the big Adder­all mar­ket just went up in smoke — and so did its stock

4 years ago
R&D

Im­muno­Gen’s ovar­i­an can­cer come­back not as rosy as ex­pect­ed as pro­gres­sion-free sur­vival lags

4 years ago
R&D

Small RSV con­tender eyes 'first-to-mar­ket' op­por­tu­ni­ty with $225M Asia deal

4 years ago
Deals
China

Mar­i­nus com­pletes its turn­around with first ap­proval of sole drug, win­ning a PRV for its ef­forts

4 years ago
R&D
FDA+

Mer­ck? Check. Roche? Check. Now Bris­tol My­ers Squibb wants As­traZeneca to pay for PD-L1 patents

4 years ago
Pharma
Law

On heels of land­mark ap­proval, Bris­tol My­ers Squibb em­barks on bil­lion-dol­lar on­col­o­gy deal with metasta­t­ic can­cer ...

4 years ago
Deals
R&D

Lat­est news on first-ever Lag-3 OK; Aduhelm sup­port, crit­i­cism both crescen­do; Phar­ma gets firm about Rus­sia; ...

4 years ago
Weekly

FDA OKs Bris­tol My­ers Squibb’s LAG-3 drug, ap­prov­ing first new class of check­point in­hibitor in 8 years

4 years ago
R&D

Te­va CEO Kåre Schultz brought home $14.7M last year, soar­ing past some of Eu­rope's top-paid phar­ma ex­ecs

4 years ago
People
Pharma

Sanofi preps API spin­off for Paris ex­change list­ing, share­hold­ers reap div­i­dend

4 years ago
Pharma
Manufacturing

Pfiz­er CEO to haul in al­most $50M in com­pen­sa­tion in 2021 and 2022

4 years ago
People
Pharma

Leen Kawas, Alzheimer’s CEO who re­signed in da­ta ma­nip­u­la­tion scan­dal, re­turns to launch in­vest­ment firm with ...

4 years ago
People

No­var­tis suf­fers a loss in its fight to block Re­genxbio's Zol­gens­ma patent ex­ten­sion

4 years ago
Pharma
Cell/Gene Tx

Not­ed: As­traZeneca re-ups lung can­cer cam­paign to send en­cour­ag­ing let­ters to pa­tients and care­givers

4 years ago
Pharma
Marketing

Il­lu­mi­na sues Guardant Health, for­mer em­ploy­ees over al­leged stolen com­pa­ny se­crets

4 years ago
Law

On the heels of FDA re­jec­tion, tiny Zosano cuts about a third of its work­force as lat­est vic­tim of the bud­get axe

4 years ago
People
Pharma

Covid-19 roundup: As­traZeneca may not file its vac­cine in the US; Iver­mectin fails to re­duce hos­pi­tal­iza­tions in ...

4 years ago
Coronavirus

Yale fac­ul­ty vo­cif­er­ous­ly de­fend stem cell pi­o­neer Haifan Lin, a sus­pend­ed col­league they say is be­ing un­fair­ly ...

4 years ago
People

Go­ing against the cur­rent, Sor­ren­to spins out pain-fo­cused sub­sidiary in $140M SPAC deal

4 years ago
Deals

Mod­er­na asks FDA to open the door for 4th Covid shots for all adults

4 years ago
Coronavirus

Mar­tin Shkre­li can't de­lay $25M pay­ment over an­ti­com­pet­i­tive case, judge rules

4 years ago
People

Hot on Roche’s heels, Mer­ck spells out mixed Keytru­da da­ta in ad­ju­vant NSCLC

4 years ago
R&D
Pharma
First page Previous page 564565566567568569570 Next page Last page
A service from the Financial Times